Zetir

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zetir

What is Zetir? (Cetirizine Hydrochloride)

This section provides a clear, factual overview of the identity, composition, and high-level classification of the medicine Zetir, without detailing administration, specific conditions, or safety information.

Property Description
Active ingredient Cetirizine Hydrochloride
Forms Tablet, oral solution, syrup, capsule
Pharmacological class H₁-Receptor Antagonist
General purpose Mitigate systemic allergic responses
Origin Synthetic compound

What Type of Medicine is Zetir?

Zetir is the trade name for a pharmaceutical product containing Cetirizine Hydrochloride, which is classified as a second-generation Antihistamine H₁-Receptor Antagonist. This synthetic compound is a piperazine derivative, explicitly developed to minimize the non-specific sedative effects common to older antihistamines. The medicine's official designation confirms its primary role as a systemic agent for the management of allergic manifestations, a use that is clinically recognized for mitigating hypersensitivity symptoms.

Composition, Origin, and Available Forms

The therapeutic effect of Zetir comes exclusively from its sole active ingredient, Cetirizine Hydrochloride, making it a single-ingredient product. The substance is a metabolite derived through synthesis in a laboratory, meaning its origin is not natural. Zetir is intended for oral administration and is widely supplied in several formats for patient convenience, including flavored syrup and oral solution alongside tablets and capsules, which supports flexible administration across different patient groups, including pediatric patients.

High-Level Purpose and Selective Action

The high-level purpose of Zetir is to provide relief by acting as a powerful histamine inhibitor at the cellular level. It functions through selective peripheral H₁-receptor blockade, which means it primarily targets the receptors responsible for allergic symptoms on cells outside the central nervous system. This focused mechanism prevents the body's natural histamine from binding and triggering acute allergic responses. The general benefit is managing the discomfort caused by systemic allergic activation, such as providing daily relief for individuals experiencing common environmental sensitivities. This action is characterized by a high affinity for peripheral H₁ receptors.

Regulatory References

  1. Cetirizine: MedlinePlus Drug Information
  2. NIH MedlinePlus

What side effects are possible with Zetir?

The officially documented safety profile for Zetir (Cetirizine Hydrochloride) details adverse reactions across various physiological systems, classified by their frequency of occurrence as reported in regulatory sources such as the EMA Summary of Product Characteristics (SmPC) and FDA labeling.

Adverse Reaction Categories

Classification Common Reactions (Examples) Affected Organ Systems (SOC)
Common Somnolence, Headache, Fatigue, Dry Mouth Nervous, General, Gastrointestinal
Uncommon/Rare Agitation, Paresthesia, Convulsions, Tachycardia, Hypersensitivity Psychiatric, Nervous, Cardiac, Immune, Skin

Serious adverse reactions, though rare, are documented in post-marketing surveillance, and include Anaphylactic Shock, Angioneurotic Edema (severe swelling), and reports of transient abnormal liver function tests.

Safety Considerations and Restrictions

The medicine is largely eliminated via the renal route, meaning that population-specific safety notes apply to individuals with renal impairment, often requiring individualized management based on kidney function. Caution is also advised for older adults, who may exhibit increased sensitivity to adverse effects.

Safety-related restrictions include the recommendation for caution in patients with factors predisposing them to urinary retention (such as prostatic hyperplasia). Furthermore, concurrent use with other Central Nervous System (CNS) depressants may cause an additional reduction in alertness. Pruritus (severe itching) after discontinuation has been reported in post-marketing data, often following long-term use, and is now explicitly included in the official safety information.

These classifications and constraints define the framework for understanding the potential risks and limitations associated with the medicine, as required by government regulatory agencies.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes overdose with Zetir (Cetirizine Hydrochloride) as presenting primarily with dose-dependent effects on the Central Nervous System (CNS) and cardiovascular system.

Feature Official Regulatory Statement
Documented Overdose Manifestations Symptoms include drowsiness, sedation, stupor, fatigue, malaise, and irritability. Effects on the cardiovascular system can manifest as tachycardia (increased heart rate) [FDA Prescribing Information].
Severe Outcomes In cases of massive ingestion, the potential for severe CNS depression and possible coma is noted in regulatory documents [SmPC].
Population Note Overdose in infants and children may specifically present with increased restlessness and irritability [NIH StatPearls].

Required Emergency Actions

It is mandatory to seek immediate medical attention for any suspected overdose or ingestion exceeding the prescribed amount [NIH MedlinePlus]. Because no specific antidote is known for Cetirizine, the officially described management involves symptomatic and supportive treatment. Procedures such as gastric lavage or administration of activated charcoal may be considered by medical professionals to limit further absorption [FDA Prescribing Information]. Close clinical observation and continuous monitoring of vital signs are required in such situations.


The regulatory profile defines overdose by its specific CNS and cardiovascular signs, escalating to severe outcomes based on the quantity ingested. This structure mandates urgent action to initiate supportive care, given the explicit regulatory statement that no specific antidote is available.

Therapeutic Uses of Zetir

What Zetir Treats: Main Uses and Benefits

The primary therapeutic role of Zetir (Cetirizine Hydrochloride) is applied across domains where additional symptomatic support is needed for allergic hypersensitivity, which helps address the overall symptom load. Its therapeutic use is centered on addressing symptoms related to systemic or localized discomfort, generally contributing to improved comfort during periods of heightened symptoms. The main uses include treating symptoms of respiratory allergies like hay fever and itching due to hives.

The medication is commonly used across conditions characterized by episodic or fluctuating upper respiratory and cutaneous symptoms, such as seasonal hay fever, year-round indoor allergies, chronic hives (urticaria), and allergic conjunctivitis. It helps address symptom clusters that create noticeable physiological strain, including sneezing, runny nose (rhinorrhea), nasal itching, and general pruritus (itching).

“Zetir is applied across domains where additional symptomatic support is needed, which may assist patients during episodes of heightened discomfort.”

Applied during phases when symptoms become more noticeable, Zetir may assist with maintaining a sense of stability when allergic symptoms are disruptive.


Quick Fact: Use in Symptomatic Management of Pruritus and Hives
Zetir is considered relevant for managing conditions presenting with disruptive skin manifestations. It is used for managing symptoms related to inflammatory or irritative states, which may assist with easing challenging symptoms like pronounced wheals and skin itching.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Zetir?

Regulatory documents define strict eligibility and non-eligibility criteria for Zetir (Cetirizine Hydrochloride), primarily based on hypersensitivity, age, and organ function status.


Absolute Prohibitions (Contraindications)

Zetir is contraindicated and must not be used by individuals with a documented hypersensitivity or allergy to the active ingredient, any excipients, or to the related compound hydroxyzine. Use is also strictly prohibited in patients with severe renal impairment, specifically when creatinine clearance is below mathbf10 mL/min per official labeling.


Eligibility by Age and Conditional Use

The medicine is generally approved for adults and adolescents mathbfge 12 years. Certain liquid formulations are approved for children as young as mathbf6 months for specific uses, though tablet forms are not recommended for those under mathbf6 years due to dose adaptation difficulties. Eligibility is conditional on organ health; patients with mathbfmoderate renal impairment or mathbfhepatic impairment require a medical dose adjustment. Regulatory bodies advise that use is not recommended during pregnancy or breastfeeding as the substance is excreted into breast milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information describes the potential for interactions primarily concerning central nervous system (CNS) depressants and one specific anti-HIV medication.

Documented Interaction Categories and Agents

Agent Category Specific Agent (if studied) Official Interaction Statement
CNS Depressants Alcohol Co-administration may cause additive CNS depression.
Antivirals (Pharmacokinetic Inhibitors) Ritonavir Increases Zetir plasma concentrations, resulting in significantly increased exposure (AUC and Cmax).
Xanthine Derivatives Theophylline Resulted in a small, clinically insignificant decrease in Zetir clearance.

Interaction Constraints and Conditions

Patients should be cautioned regarding the concurrent use of alcohol or other CNS depressants due to the risk of additive effects. The interaction with Ritonavir, which is classified as clinically significant, is due to a pharmacokinetic mechanism resulting in altered clearance and increased systemic exposure to Zetir.

No clinically significant pharmacokinetic interactions were observed in official studies with several other agents, including Azithromycin, Cimetidine, Erythromycin, Ketoconazole, or Pseudoephedrine. The overall interaction profile is structured around minimizing the risk of enhanced sedation and managing exposure when combined with the strong inhibitor Ritonavir.

Mechanism of Action

Zetir functions as a highly selective antagonist of the peripheral histamine H1 receptor. Following absorption, the compound exhibits high affinity for the H1 receptor, which is expressed on various cell types including vascular endothelial cells and smooth muscle cells.

By competitively binding to the H1 receptor, Zetir prevents the subsequent binding and activity of endogenous histamine. This action blocks the cascade of intracellular signaling typically initiated by histamine release from mast cells and basophils. The consequence of this peripheral H1 blockade is a reduction in microvascular permeability and a suppression of the resulting fluid extravasation into tissues.

Furthermore, Zetir demonstrates H1-receptor-independent modulation of inflammatory processes. It has been shown to inhibit the chemotaxis and activation of various immune cells, including eosinophils and neutrophils, at the site of inflammation. This dual action, combining selective receptor antagonism with anti-inflammatory pathway modulation, alters the physiological response to various immunological challenges.

Dosage and Administration Information

The use of Zetir (Cetirizine Hydrochloride) is governed by specific instructions regarding its administration and dosing limits.

Administration Scope

The primary route of administration is Oral, supplied in forms like tablets, capsules, and solutions. An Intravenous (IV) injection form is also approved for acute use in supervised clinical settings. The medicine may be taken with or without food.

Official Dosing and Frequency

The standard dosing schedule for adults and adolescents (12 years and older) is 10 mg taken once daily, which also represents the mandatory maximum daily dose. For the pediatric population, dosing is age-dependent; children aged 6 to 11 years typically receive 5 mg or 10 mg daily, either as a single dose or divided twice daily.

Population-Specific Adjustments

Established protocols mandate population-specific adjustments based on physiological function. For older adults and patients with moderate renal impairment, the dose must typically be reduced to 5 mg once daily, as the medicine is primarily eliminated by the kidneys. If a dose is missed, patients should generally resume their regular schedule and not attempt to compensate with a double dose. This protocol establishes a standardized once-daily regimen with critical limits for both maximum strength and necessary dose reductions.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Zetir


Evidence for Use in Seasonal Allergic Rhinitis (SAR)

Research explored Zetir in studies of Seasonal Allergic Rhinitis (SAR), commonly known as hay fever, primarily involving short-term Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time when compared to an inactive substance (placebo) and other studied treatments. Researchers monitored Total Symptom Scores (TSS), a measure designed to capture symptoms such as sneezing, runny nose, and itching of the nose and eyes, and assessed outcomes reflecting daily functioning.

The findings from these numerous clinical studies describe patterns observed in the studies related to a recorded change in these symptom scores during the defined treatment period. However, the majority of this definitive data is based on trials lasting only 2 to 6 weeks. This means that there is limited information for long-term outcomes, and the durability of any measured effect over an entire season is not well characterized.


Evidence for Use in Chronic Urticaria (Hives and Itching)

For the study of Chronic Urticaria (long-lasting hives) and the associated itching (pruritus), research includes short-term RCTs and some smaller studies designed to look at patients whose symptoms were not fully addressed by initial doses. Studies monitored changes in specific outcome scales like the Urticarial Activity Scores (UAS), which measure both the severity of the itching and the size/number of the wheals (hives).

Findings describe group patterns related to a change in measured symptoms over the observed time intervals. A key research limitation is that the definitive trials are generally very short-term, typically only 1 to 4 weeks, which means the follow-up durations were limited for a condition that is chronic. Furthermore, evidence supporting use at doses higher than the standard licensed dose is often based on studies where the sample sizes were modest, meaning that certainty remains low regarding this specific research scenario.


Long-Term Studies and What is Still Uncertain

The most structured and methodologically controlled evidence for Zetir comes from short-term RCTs. While some longer open-label studies have been used in research contexts involving fluctuating symptoms, these studies are primarily designed to collect information on safety rather than to definitively measure the durability of the symptomatic change.

This means that for all studied indications, long-term effects are not well characterized based on the primary clinical trial evidence. The evidence landscape consistently notes limitations, including that follow-up durations were limited, and comparative evidence against all other available treatments is still emerging, making certain subgroup findings uncertain.

Key Studies & References

  1. Cetirizine for seasonal allergic rhinitis in children aged 2-6 years. A double-blind comparison with placebo

Frequently Asked Questions (FAQ)

Common questions about Zetir (FAQ)

Q: What is Zetir typically prescribed for?

According to the official product information, Zetir (Cetirizine Hydrochloride) is officially approved and prescribed for the relief and treatment of symptoms associated with common allergic conditions. These include Seasonal Allergic Rhinitis (hay fever) and Chronic Urticaria (long-lasting hives and associated itching).


Q: Is Zetir considered a first-line treatment option?

Official clinical guidelines often refer to the class of medicine to which Zetir belongs—known as second-generation antihistamines—as being among the first-line agents for managing common conditions like allergic rhinitis and chronic hives. This classification reflects its established role in patient care.


Q: What is the difference between Zetir and the other common medicine (X)?

Zetir is classified as a second-generation H₁-Receptor Antagonist (antihistamine). This selective focus is a key pharmacological feature designed to act on peripheral receptors, which is cited in studies as having less potential for non-specific sedative effects compared to older antihistamines.


Q: Does Zetir treat the actual condition or just the symptoms?

Official regulatory information describes Zetir as working primarily by blocking the activity of histamine, a natural compound that triggers allergic reactions. This action mitigates the systemic allergic responses in the body, which helps to provide relief from allergic symptoms like itching, runny nose, and hives.


Q: Is there a generic version of Zetir available, and is it the same?

Yes, generic versions of the active ingredient, Cetirizine Hydrochloride, are available. Regulatory bodies, such as the FDA and EMA, approve a generic only after studies establish that it is bioequivalent to the original product. Bioequivalence means the generic delivers the same amount of the active ingredient into the bloodstream at the same rate.


Q: How long does it usually take for Zetir to start working?

Pharmacology studies indicate that the effects of Zetir generally begin relatively quickly after taking the medicine. Onset is typically observed within 30 minutes to an hour after oral administration.


Q: What is the typical timeframe or duration for using Zetir?

The duration of use is typically guided by the chronic or acute nature of the condition being addressed. For chronic conditions like chronic urticaria, medical management often includes long-term administration. The specific duration of use is discussed with a healthcare provider.


Q: What percentage of people experience the serious side effects of Zetir?

Official regulatory documents classify side effects by their frequency, such as Common, Uncommon, or Rare. While serious adverse reactions are documented, regulatory agencies generally do not list specific percentage rates for those serious effects reported from post-marketing surveillance.


Q: Is weight gain or loss a known side effect of Zetir?

Reports of weight increase have been noted as an adverse reaction in clinical experience with the medicine. Official safety information should be consulted for a complete overview of documented reactions.


Q: Why does the official information list so many possible side effects?

Regulatory agencies require that official product information lists all adverse events that were observed during the development and clinical trials of the medicine. This approach is required to ensure that all events observed during development and post-marketing are included in the official safety summary.


Q: Can Zetir be taken alongside common over-the-counter pain relievers?

Official drug interaction studies have not reported a clinically significant interaction between Cetirizine and common pain relievers such as ibuprofen or acetaminophen. However, it is important to be aware of the full interaction profile for all medicines being used.


Q: Does Zetir interact with everyday foods or drinks like coffee or grapefruit juice?

Regulatory pharmacokinetic studies indicate that while taking Zetir with food may slightly delay the time it takes to reach its highest concentration in the bloodstream, it does not affect the overall amount of the medicine that the body absorbs.


Q: Are there specific vitamins or herbal supplements known to interact with Zetir?

Official drug interaction studies focus on prescription medications. No specific vitamin, mineral, or common herbal supplement interactions are documented in the official regulatory texts. Official regulatory texts describe the drug’s interaction profile with pharmaceuticals.


Q: Does Zetir build up in the body over time?

Pharmacokinetic studies were performed following repeated daily dosing of the medicine. The research showed no significant accumulation of the drug in the body during the period of chronic administration that was studied.


Q: What is the process for determining which side effects get listed on the label?

Regulatory agencies require that drug labels include both the adverse reactions identified in controlled clinical trials and those reported in post-marketing surveillance. This continuous process ensures that the official safety information reflects data gathered from both clinical trials and post-market surveillance.


Q: Is Zetir a controlled substance?

Zetir (Cetirizine Hydrochloride) is not classified as a controlled substance in the United States or other major regulated markets. This classification confirms that it is not subject to the specific restrictions placed on controlled substances.


Q: Can taking Zetir affect the results of certain lab tests?

Yes, as an antihistamine, Zetir is known to interfere with the results of skin prick allergy tests. Because of this interference, temporary discontinuation may be necessary before such testing.


Q: Is it true that Zetir can interact with birth control pills?

Official drug interaction studies have not reported a clinically significant interaction between Zetir and oral contraceptives (birth control pills). Official interaction studies found no clinically significant alteration of the concentrations of oral contraceptives.


Q: What do the official guidelines say about stopping Zetir suddenly?

Official regulatory documents note that following long-term use, some individuals have reported experiencing severe pruritus (itching) upon stopping the medicine. Official information indicates that any changes to the regimen should be guided by a healthcare professional.


Q: Why do some people say they felt worse when they first started taking Zetir?

When starting the medicine, patients may experience common side effects such as somnolence (drowsiness), headache, or fatigue. These effects are listed in the official safety profile as common reactions, often described as mild to moderate in severity.


Q: Is there a reason Zetir has to be taken at a specific time of day?

Zetir has a long duration of action in the body. Due to this property, the official recommended regimen is a once-daily dose to maintain consistent effectiveness throughout the day.


Q: Does Zetir have a known risk for dependency or withdrawal symptoms?

Zetir is not classified as a controlled substance. However, official information includes reports of severe itching (pruritus) that can occur after stopping the medicine following long-term use, which is a post-cessation symptom.


Q: What is the risk of an allergic reaction to Zetir?

Zetir is strictly contraindicated for anyone with a known hypersensitivity or allergy to the active ingredient. Severe allergic reactions, such as anaphylaxis (a serious, rapid reaction) or angioedema (severe swelling), are classified as uncommon or rare adverse reactions in official safety profiles.


Q: Does my medical history influence whether Zetir is a safe choice?

Yes, your overall health history is a key factor. Official information mandates dose adjustments or contraindications for patients with severe renal impairment (kidney issues) and requires caution in those with hepatic impairment (liver issues). The need for dose adjustments is based on the role of these organs in processing the medicine.

How should Zetir be stored and disposed of?

How to Store and Dispose of Zetir?

The storage and disposal of Zetir (Cetirizine Hydrochloride) must strictly follow the conditions defined in official regulatory labeling to ensure product stability and safety.

Storage Conditions

Requirement Specific Condition
Temperature Store at Controlled Room Temperature, between 20^circC and 25^circC (68^circF and 77^circF).
Protection Keep in the original container, protected from moisture and light.
Container Rule Liquid forms must be kept with the container tightly closed.
Child Safety Store the medicine out of the sight and reach of children.

Disposal Instructions

Unused or expired Zetir should be disposed of through an authorized drug take-back program. Official guidelines advise not to dispose of the medicine by pouring it into wastewater or mixing it with household trash unless explicitly instructed to do so by a regulated program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zetir found in:

A-Z Index: